The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Mosharraf, M., & Nyström, C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00033-f · Cited by 386
The effect of particle size distribution on dissolution rate and oral absorption
HINTZ, R., & JOHNSON, K. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90069-0 · Cited by 331
Solid-state characterization of nifedipine solid dispersions
Vippagunta, S. R., Maul, K. A., Tallavajhala, S., & Grant, D. J. W. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00019-4 · Cited by 206
Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders
Lu, A. T. K., Frisella, M. E., & Johnson, K. C. (1993) · Pharmaceutical Research · doi:10.1023/a:1018917729477 · Cited by 166
Improvement of nifedipine dissolution characteristics using supercritical CO2
Senčar-Božič, P., Srčič, S., Knez, Ž., & Kerč, J. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04838-7 · Cited by 89
Lin, C. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04245-8 · Cited by 81
Mitchell, S. A., Reynolds, T. D., & Dasbach, T. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00293-4 · Cited by 74
Characterization of nifedipine solid dispersions
Cilurzo, F., Minghetti, P., Casiraghi, A., & MONTANARI, L. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00173-4 · Cited by 66
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Nanonization strategies for poorly water-soluble drugs
Chen, H., Khemtong, C., Yang, X., Chang, X., & Gao, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.009 · Cited by 642
Metadata
- Authors
- Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 299
- Issue
- 1-2
- Pages
- 167-177
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2083642073
- Cited by
- 339
- References
- 12
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. https://app.cochat.ai/papers/10.1016/j.ijpharm.2005.05.014
- The paper
- Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2005.05.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.